Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
EXT608
DRUG
2 trials
Sponsors
Extend Biosciences Inc.
Conditions
Hypoparathyroidism
Safety Issues
Phase 1
A Phase 1 Study of EXT608 in Healthy Adults
Completed
NCT05408663
Extend Biosciences Inc.
Safety Issues
Start: 2022-07-21
End: 2023-06-13
Updated: 2025-02-04
Phase 2
A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism
Recruiting
NCT06988670
Extend Biosciences Inc.
Hypoparathyroidism
Start: 2025-05-05
End: 2027-05-31
Target: 35
Updated: 2025-05-25